Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06099782
Title A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | POL | NZL | FRA | AUS | ARG

Facility Status City State Zip Country Details
Russell Medical ( Site 0160) Alexander City Alabama 35010 United States Details
Alaska Oncology and Hematology ( Site 0121) Anchorage Alaska 99508 United States Details
Highlands Oncology Group-Research Department ( Site 0133) Springdale Arkansas 72762 United States Details
Marin Cancer Care ( Site 0148) Greenbrae California 94904 United States Details
Holy Cross Hospital-Clinical Research ( Site 0159) Fort Lauderdale Florida 33308 United States Details
Mid Florida Hematology and Oncology Center ( Site 0113) Orange City Florida 32763 United States Details
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0112) Marietta Georgia 30060 United States Details
Kadlec Clinic Hematology and Oncology ( Site 0103) Kennewick Washington 99336 United States Details
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300) Mar del Plata Buenos Aires B7600FZO Argentina Details
Fundación Respirar ( Site 0302) Buenos Aires Caba C1426ABP Argentina Details
Instituto San Marcos ( Site 0305) San Juan J5400EBB Argentina Details
Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 1001) Port Macquarie New South Wales 2444 Australia Details
Frankston Hospital-Oncology and Haematology ( Site 1007) Frankston Victoria 3199 Australia Details
Centro Investigacion Cancer James Lind ( Site 0408) Temuco Araucania 4800827 Chile Details
Clínica Puerto Montt ( Site 0404) Puerto Montt Los Lagos 5500243 Chile Details
FALP-UIDO ( Site 0401) Santiago Region M. De Santiago 7500921 Chile Details
Oncovida ( Site 0403) Santiago Region M. De Santiago 7500994 Chile Details
Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0407) Santiago Region M. De Santiago 8330032 Chile Details
Bradfordhill-Clinical Area ( Site 0402) Santiago Region M. De Santiago 8420383 Chile Details
ONCOCENTRO APYS-ACEREY ( Site 0400) Viña del Mar Valparaiso 2520598 Chile Details
Centre Hospitalier Universitaire de Caen Normandie-DERMATOLOGY ( Site 0604) Caen Calvados 14000 France Details
Clinique Francois Chenieux ( Site 0603) Limoges Haute-Vienne 87039 France Details
Hôpital Bichat - Claude-Bernard ( Site 0605) Paris Ile-de-France 75018 France Details
CENTRE LEON BERARD-onco dermatology ( Site 0600) Lyon Cedex08 Rhone-Alpes 69373 France Details
HIA Sainte Anne-Pneumology ( Site 0601) Toulon Var 83800 Cedex 9 France Details
Bell Land General Hospital ( Site 1101) Sakai Osaka 599-8247 Japan Details
Tokyo Women's Medical University ( Site 1100) Tokyo 162-8666 Japan Details
Auckland City Hospital-Cancer & Blood Research ( Site 1051) Auckland 1023 New Zealand Details
Bowen Hospital ( Site 1050) Wellington 6035 New Zealand Details
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 0701) Bydgoszcz Kujawsko-pomorskie 85-796 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier Warszawa Mazowieckie 02-781 Poland Details
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0702) Koszalin Zachodniopomorskie 75-581 Poland Details
Zachodniopomorskie Centrum Onkologii ( Site 0703) Szczecin Zachodniopomorskie 71-730 Poland Details
Cancer Care Langenhoven Drive Oncology Centre ( Site 0808) Port Elizabeth Eastern Cape 6045 South Africa Details
Medical Oncology Centre of Rosebank ( Site 0805) Johannesburg Gauteng 2196 South Africa Details
Nosworthy Oncology ( Site 0807) Johannesburg Gauteng 2196 South Africa Details
Steve Biko Academic Hospital-Medical Oncology ( Site 0804) Pretoria Gauteng 0001 South Africa Details
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 0800) Pretoria Gauteng 0181 South Africa Details
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 0801) Sandton Gauteng 2196 South Africa Details
Cape Town Oncology Trials ( Site 0802) Cape Town Western Cape 7570 South Africa Details
CANCERCARE RONDEBOSCH ONCOLOGY-Cancercare Rondebosch Oncology ( Site 0806) Cape Town Western Cape 7700 South Africa Details
Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 0903) Adana 01140 Turkey Details
Hacettepe Universite Hastaneleri-oncology hospital ( Site 0900) Ankara 06230 Turkey Details
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 0901) Ankara 06800 Turkey Details
Ege Universitesi Hastanesi ( Site 0902) İzmir 35100 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field